Vetsuccess CEO shares an insider’s look at clinical dynamics within the practice management system at 2016 senior executive forum
This press release was originally published by Animalytics. We thought we’d share it on our blog as it references a talk our CEO Martin Traub-Werner gave on a study we conducted on core vaccination frequency (Distemper- Adenovirus-Parvovirus) over a four-year period in a 300 practice sample.
Kansas City, MO, May 16, 2016
Martin Traub-Werner, CEO of VetSuccess, a leading provider of data driven practice management solutions, presented the industry’s first analysis of vaccine utilization patterns in canine and feline patients. Vet Success provides detailed reporting services to more than 1,000 veterinary clinics and hospitals in the United States and Canada and utilized a data set of data of more than 300 small animal practices to complete this most recent study.
Within the sample population of hospitals, more than 140,000 canine patients were identified as receiving continuity of care for the period of 2012 – 2015. When reviewing core vaccination frequency (Distemper- Adenovirus-Parvovirus) over a four-year period within this patient group, the following trends were observed.
- Annual core vaccination remains the most popular vaccination protocol in practice. – Within this specific patient group, 42% received a core vaccination annually through the observation period. This is far greater than the next common protocol of 36 months at 9.2%,
- One quarter of all patients find vaccines outside of the primary care environment. – Over the four-year observation period, 25% of all dogs received 1 or no core vaccinations. These findings suggest that a significant subset of “loyal” clients are failing to implement clinical recommendations of their veterinary care provider or finding those services from an alternative source.
- Extended duration protocols are not standard of care. – Almost a decade following the licensing of the first three-year duration of immunity core vaccine, the implementation of extended protocols is still an exception. Among the entire test population, less than 10% of all patients received core vaccinations on a 3-year pattern.
Traub-Werner also presented core vaccination patterns in feline patients as well, utilizing a sample set of more than 30,000 cats. The results were surprisingly similar to trends observed in the canine patient population. When reviewing core vaccination frequency (Feline Rhinotracheitis – Calicivirus – Panleukopenia) over a four-year period within this patient group, the following trends were observed.
- Annual core vaccination is also the most frequent applied protocol in feline patients. Within this data set, 32.6% of patients were vaccinated on 12-month interval compared to the next most frequent protocol of 36-months (10.7%).
- Approximately half of all feline patients within this data set fall below standards of compliance as their vaccination patterns do not fall within an annual, every other year, or every three-year vaccination protocol.
- Almost 1 in 5 feline patients are totally non-compliant, suggesting owners are electing not to vaccinate their cat at all or to find vaccination services from an alternative provider to their family veterinarian.
In addition to the vaccination pattern analysis, Traub-Werner’s presentation also introduced the concept of implementing a standard scorecard methodology to identify variances in patient compliance for many common clinical metrics including: wellness exams, annual vaccinations, heartworm diagnostics, dentals and dispensing of flea, tick and heartworm preventatives.
Traub-Werner noted the data presented marked the early stages of this type of analysis, noting the next step was to move within the practice walls to assess differences among individual veterinarians providing care at a given practice.
About Animalytix LLC
Animalytix, through its partnership with the leading US animal health distribution companies, is unique in its ability to provide actionable commercial insight to manufacturers, investors, lenders and financial analysts with an interest in this dynamic and expanding market. Animalytix currently publishes reports on more than 30 market segments, reflecting sales of pharmaceuticals, vaccines, nutraceuticals and veterinary supplies for use in pets, horses, swine and cattle totaling $6.5 billion in annual sales revenues. The monthly surveys provide sales trending insights for more than 8,000 products sourced from over 500 manufacturers. For more information, please contact: email@example.com, or visit: www.animalytix.net.